| AASLD

Distal Gastroduodenal Arterial Inflow as a Salvage Strategy for Extensive Intraoperative Arterial Dissection in Living Donor Liver Transplantation

Read more about Distal Gastroduodenal Arterial Inflow as a Salvage Strategy for Extensive Intraoperative Arterial Dissection in Living Donor Liver Transplantation

Ramkiran Cherukuru, Pradeep Krishna, Guruprasad Shetty, Ashwin Rammohan, Mettu Srinivas Reddy, Mohamed Rela – 17 January 2021

Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD

Read more about Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD

Kara Wegermann, Melanie E. Garrett, Jiayin Zheng, Andrea Coviello, Cynthia A. Moylan, Manal F. Abdelmalek, Shein‐Chung Chow, Cynthia D. Guy, Anna Mae Diehl, Allison Ashley‐Koch, Ayako Suzuki – 17 January 2021 – The development of fibrosis in nonalcoholic fatty liver disease (NAFLD) is influenced by genetics, sex, and menopausal status, but whether genetic susceptibility to fibrosis is influenced by sex and reproductive status is unclear.

REPLY:

Read more about REPLY:

Hye‐Mee Kwon, Hwa‐Young Jang, Gyu‐Sam Hwang – 17 January 2021

Ceramide Salvage, Gut Mucosal Immunoglobulin A Signaling, and Diet‐Induced NASH

Read more about Ceramide Salvage, Gut Mucosal Immunoglobulin A Signaling, and Diet‐Induced NASH

Scott A. McHenry, Nicholas O. Davidson – 14 January 2021

Endoscopic Cyanoacrylate Injection Versus Balloon‐Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Bleeding: A Randomized Controlled Trial

Read more about Endoscopic Cyanoacrylate Injection Versus Balloon‐Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Bleeding: A Randomized Controlled Trial

Xuefeng Luo, Tong Xiang, Junchao Wu, Xiaoze Wang, Yongjun Zhu, Xiaotan Xi, Yuling Yan, Jinlin Yang, Juan Carlos García‐Pagán, Li Yang – 13 January 2021

The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007‐2017

Read more about The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007‐2017

James M. Paik, Pegah Golabi, Youssef Younossi, Nazaneen Saleh, Annan Nhyira, Zobair M. Younossi – 13 January 2021 – Chronic liver disease (CLD) causes significant morbidity and mortality in the United States with regional variations. Comparable and consistent state‐level measures of CLD‐related morbidity and disability among U.S. states have not been well studied.